Unless our esteemed, highly paid and over exuberant CEO who has hyped LymPro as being the next Big Thing can substantiate and clearly articulate REVENUE, then we all continue to sit in a circle jerk wondering WTF is going on. This is simply pathetic folks - that we would be at this stage well over 2 + years in and still be assuming what the real projections are. This is one reason (of many) as to why I continue to say Gerald is simply too young to be a credible and qualified CEO.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links